02190 ZYLOXTB-B
- 10.800
- +0.240+2.27%
ZYLOXTB-B News
ZYLOXTB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
ZYLOXTB-B: Next Day Disclosure Return
ZYLOXTB-B: Next Day Disclosure Return
ZYLOXTB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
ZYLOXTB-B: VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED MARKETING APPROVAL FOR TONBRIDGE QILIN FLOW DIVERTER
ZYLOXTB-B: VOLUNTARY ANNOUNCEMENT - LICENSING AND INVESTMENT AGREEMENTS WITH AVINGER INC.
ZYLOXTB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
ZYLOXTB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
ZYLOXTB-B: VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED MARKETING APPROVAL FOR ZYLOX PENGUIN PERIPHERAL VENOUS STENT SYSTEM
ZYLOXTB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
ZYLOXTB-B: Next Day Disclosure Return
ZYLOXTB-B: New Arrangements on Dissemination of Corporate Communications
ZYLOXTB-B: VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED MARKETING APPROVAL FOR ZYLOX PHOENIX PERIPHERAL DETACHABLE FIBROUS COIL EMBOLIZATION SYSTEM
ZYLOXTB-B: Next Day Disclosure Return
ZYLOXTB-B: Next Day Disclosure Return
ZYLOXTB-B: Next Day Disclosure Return
ZYLOXTB-B: Next Day Disclosure Return
ZYLOXTB-B: VOLUNTARY ANNOUNCEMENT - COMPLETION OF PATIENT ENROLLMENT FOR THE ZENFLEX PERIPHERAL STENT SYSTEM POST-MARKETING CLINICAL TRIAL IN THE EUROPEAN UNION
ZYLOXTB-B: Next Day Disclosure Return
ZYLOXTB-B: Next Day Disclosure Return
Analysis
Price Target
No Data
